Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11609 results
-
Coronavirus (COVID-19) at a glance – 1 March 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 March 2022 -
COVID-19 vaccine rollout update – 2 March 2022
This presentation, delivered on 2 March 2022, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 2 March 2022
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccination – Disability provider alert 2 March 2022
This alert contains updates for disability service providers about the COVID-19 vaccination rollout. -
Primary care Rural Innovative Multidisciplinary Models (PRIMM) – Round 2 Grant GO5102
This document gives feedback for applicants of the PRIMM round 2 grant opportunity, which is overseen by the Office of the National Rural Health Commissioner. -
Coronavirus (COVID-19) at a glance – 28 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 28 February 2022 -
COVID-19 vaccine rollout update – 1 March 2022
This presentation, delivered on 1 March 2022, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 1 March 2022
This data file contains statistical data about Australia's COVID-19 vaccinations. -
Coronavirus (COVID-19) common operating picture – 1 March 2022
This infographic issued on 1 March 2022 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
Natural Therapies Review 2024 – Rolfing evidence evaluation
This report outlines the evaluation of evidence on the clinical effectiveness of Rolfing as part of the Natural Therapies Review 2024. -
Allied Health Industry Reference Group meeting summaries
This collection contains meeting summaries from the Allied Health Industry Reference Group. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix C – Modified MRC respiratory questionnaire
This questionnaire helps general practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix D – Modified MRC dyspnoea scale
This scale helps general practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix E – Spirometry case study
This case study shows how to appropriately determine a change in spirometry over time in an individual exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Administrative report
This administrative report outlines how the National Dust Disease Taskforce developed national guidance for doctors assessing workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust
The national guidance and associated documents provide a framework to identify workers exposed to respirable crystalline silica dust, and supports medical practitioners to carry out health surveillance within their specific training and experience. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust
The national guidance provides a framework to identify workers exposed to respirable crystalline silica dust and support medical practitioners carry out health surveillance within their specific training and experience. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Summary
The document summarises the national guidance for doctors assessing workers exposed to respirable crystalline silica dust. -
National Guidance for doctors assessing workers exposed to respirable crystalline silica dust – Practice guide
This practice guide provides medical practitioners with guidance on identifying and assessing workers exposed to respirable crystalline silica dust, and carrying out health assessments and surveillance. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix A – Exposure Risk Matrix
This exposure risk matrix assists medical practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix B – Shared decision making tool
This decision aid helps patients exposed to respirable crystalline silica (RCB) dust decide their next steps, including if they should keep working. -
Coronavirus (COVID-19) at a glance – 27 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 27 February 2022 -
Coronavirus (COVID-19) at a glance – 26 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 26 February 2022 -
Coronavirus (COVID-19) at a glance – 25 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 25 February 2022 -
Clinical Advisory Committee advice: Consistent protocols on radial scars
BreastScreen Australia Clinical Advisory Committee endorsed advice regarding the management of Radial Scar/Complex Sclerosing Lesion.